Holistic Health Philosophy: Promoting long-term health habits rather than unsustainable quick results
For more information about office-based proton therapy at KCPI and helpful tips for your healthcare journey, visit our Facebook page.
doi: 10.5653/cerm.2023.06779 62 GengJQiuYLiYLiJLiaoRDuHet al
14.3 Clinical Studies in Patients with Type 2 Diabetes Uncontrolled on Basal Insulin A total of 736 patients with type 2 diabetes participated in a randomized, 30-week, active-controlled, open-label, 2-treatment arm, parallel-group, multicenter study (Study B: NCT02058160) to evaluate the efficacy and safety of SOLIQUA 100/33 compared to insulin glargine 100 units/mL
Potential Side Effects and Precautions Known Adverse Reactions and Risk Factors Most users tolerate BPC 157 well, but reported side effects may include: Mild injection-site redness or irritation Occasional headache or nausea Possible blood-pressure changes, especially in people with hypertension Because high-quality human safety data are limited, users should monitor symptoms carefully and consult a healthcare professional if unusual effects appear
WB analysis Protein extracts from treated cells were prepared using WB/IP lysis buffer